These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 20079922

  • 1. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW, Fluocinolone Acetonide Study Group.
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P.
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [Abstract] [Full Text] [Related]

  • 3. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T, Fluocinolone Acetonide Uveitis Study Group.
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [Abstract] [Full Text] [Related]

  • 4. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
    Malone PE, Herndon LW, Muir KW, Jaffe GJ.
    Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
    [Abstract] [Full Text] [Related]

  • 5. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
    Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL.
    Arch Ophthalmol; 2008 Sep; 126(9):1191-201. PubMed ID: 18779477
    [Abstract] [Full Text] [Related]

  • 6. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
    Bollinger K, Kim J, Lowder CY, Kaiser PK, Smith SD.
    Ophthalmology; 2011 Oct; 118(10):1927-31. PubMed ID: 21652079
    [Abstract] [Full Text] [Related]

  • 7. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
    Jaffe GJ.
    Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
    [Abstract] [Full Text] [Related]

  • 8. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
    Chieh JJ, Carlson AN, Jaffe GJ.
    Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
    [Abstract] [Full Text] [Related]

  • 9. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
    Patel CC, Mandava N, Oliver SC, Braverman R, Quiroz-Mercado H, Olson JL.
    Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
    [Abstract] [Full Text] [Related]

  • 10. Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis.
    Oh EK, Lee EK, Yu HG.
    Can J Ophthalmol; 2014 Jun; 49(3):273-8. PubMed ID: 24862774
    [Abstract] [Full Text] [Related]

  • 11. Scleral thickness following fluocinolone acetonide implant (Retisert).
    Taban M, Lowder CY, Ventura AA, Sharma S, Nutter B, Hayden BC, Dupps WJ, Kaiser PK.
    Ocul Immunol Inflamm; 2010 Aug; 18(4):305-13. PubMed ID: 20482407
    [Abstract] [Full Text] [Related]

  • 12. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
    Jaffe GJ, Lin P, Keenan RT, Ashton P, Skalak C, Stinnett SS.
    Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
    [Abstract] [Full Text] [Related]

  • 13. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A, Srivastava S, Bena J, Albini T, Nguyen QD, Goldstein DA.
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [Abstract] [Full Text] [Related]

  • 14. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA, Cerón OM, Foster CS.
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [Abstract] [Full Text] [Related]

  • 15. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
    Jaffe GJ, Foster CS, Pavesio CE, Paggiarino DA, Riedel GE.
    Ophthalmology; 2019 Apr; 126(4):601-610. PubMed ID: 30367884
    [Abstract] [Full Text] [Related]

  • 16. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants.
    Goldstein DA, Godfrey DG, Hall A, Callanan DG, Jaffe GJ, Pearson PA, Usner DW, Comstock TL.
    Arch Ophthalmol; 2007 Nov; 125(11):1478-85. PubMed ID: 17923537
    [Abstract] [Full Text] [Related]

  • 17. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
    Ozkiris A.
    Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
    Multicenter Uveitis Steroid Treatment (MUST) Trial Research GroupOcular Inflammation Service, The University of Pennsylvania, Philadelphia, Philadelphia, PA 19104, USA., Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE.
    Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
    [Abstract] [Full Text] [Related]

  • 20. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
    Pearson PA, Comstock TL, Ip M, Callanan D, Morse LS, Ashton P, Levy B, Mann ES, Eliott D.
    Ophthalmology; 2011 Aug; 118(8):1580-7. PubMed ID: 21813090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.